The closing price of Gritstone Bio Inc (NASDAQ: GRTS) was $2.73 for the day, up 11.43% from the previous closing price of $2.45. In other words, the price has increased by $+0.2800 from its previous closing price. On the day, 1982606 shares were traded.
Ratios:
Our analysis of GRTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.21.
On March 28, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $8.
On October 31, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $6.Piper Sandler initiated its Overweight rating on October 31, 2022, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 23 when Economides Vassiliki bought 12,000 shares for $1.90 per share. The transaction valued at 22,829 led to the insider holds 214,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTS now has a Market Capitalization of 260.28M and an Enterprise Value of 271.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 98.97 while its Price-to-Book (P/B) ratio in mrq is 3.43. Its current Enterprise Value per Revenue stands at 103.32 whereas that against EBITDA is -2.12.
Stock Price History:
Over the past 52 weeks, GRTS has reached a high of $3.33, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 2.2704, while the 200-Day Moving Average is calculated to be 1.9754.
Shares Statistics:
GRTS traded an average of 1.90M shares per day over the past three months and 1.24M shares per day over the past ten days. A total of 95.34M shares are outstanding, with a floating share count of 86.93M. Insiders hold about 8.82% of the company’s shares, while institutions hold 39.47% stake in the company. Shares short for GRTS as of Jan 31, 2024 were 8.99M with a Short Ratio of 4.73, compared to 8.95M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.43% and a Short% of Float of 10.68%.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of -$0.34 for the current quarter, with a high estimate of -$0.29 and a low estimate of -$0.42, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.3 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.23 and -$1.47 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is -$1.1, with 6 analysts recommending between -$0.58 and -$1.49.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for GRTS’s current fiscal year. The highest revenue estimate was $16.64M, while the lowest revenue estimate was $6M, resulting in an average revenue estimate of $9.88M. In the same quarter a year ago, actual revenue was $19.95M, down -50.50% from the average estimate.
